Patient characteristics | miR-221 | miR-374 | ||||
---|---|---|---|---|---|---|
High expression | Low expression | P-value | High expression | Low expression | P- value | |
Age1, years | 22.8 (1 – 66) | 17.4 (2 – 44) | 0.22 | 23.6 (1 – 66) | 16.8 (2 – 44) | 0.49 |
Gender (M/F) | 24(18/6) | 24 (21/3) | 0.46 | 24(21/3) | 23(17/6) | 0.12 |
Mediastinal mass (%) | 14/24(58) | 6/24 (25) | 0.15 | 15/24 (62.5) | 5/23(22) | 0.13 |
Lymphadenopathy (%) | 15/24(62.5) | 21/24 (87.5) | 0.26 | 16/24 (67) | 19/23(83) | 0.24 |
Splenomegaly (%) | 16/24(67) | 16/24 (67) | 0.66 | 17/24 (71) | 14/23(61) | 0.6 |
Hepatomegaly (%) | 15/24(62.5) | 16/24 (67) | 0.99 | 17/24 (71) | 13/23(56.5) | 0.44 |
CNS involvement (%) | 1/24(4) | 2/24 (8) | 0.56 | 2/24 (8) | 1/23(4) | 0.53 |
Blasts BM1 (%) | 77.3 (20 – 100) | 90.5 (28 – 100) | 0.09 | 77.6 (20 – 100) | 90.7 (28 – 100) | 0.64 |
Blasts PB1 (%) | 63.4 (0 – 100) | 78.5 (10 – 100) | 0.18 | 61.5 (0 – 100) | 86 (10 – 100) | 0.45 |
Hemoglobin1 (g/l) | 10.4 (3.6 – 15.6) | 10.4 (4.6 – 17.1) | 0.97 | 10.1 (3.6 – 15.8) | 10.8 (5.3 – 17.1) | 0.4 |
WBC1 count × 109/l | 104 (4.6 – 314) | 202.3 (4.5 – 790) | 0.06 | 118 (4.5 – 781) | 196 (18 – 789) | 0.61 |
Platelets1 × 109/l | 149.4 (9 – 652) | 48.8 (9 – 185) | 0.009* | 140 (9 – 652) | 55.8 (9 – 231) | 0.03* |
Pre thymic (%) | 7/24(29) | 4/24(17) | 0.31 | 6/24 (25) | 5/23(22) | 0.81 |
Thymic (%) | 7/24(29) | 10/24(42) | 0.54 | 9/24 (37.5) | 7/23(30) | 0.51 |
Mature T (%) | 8/24(33) | 8/24(33) | 0.98 | 7/24 (29) | 9/23(39) | 0.37 |
CD34 (%) | 16/24(67) | 8/24(33) | 0.042* | 13/24 (54) | 11/23(48) | 0.56 |
CD56 (%) | 11/24(46) | 1/24(4) | 0.001* | 12/24 (50) | 1/23(4) | <0.001* |
TdT (%) | 18/24(75) | 21/24(87) | 0.46 | 17/24 (71) | 21/23(91) | 0.28 |